XAMPENSO

Serial Number 87899784
606

Registration Progress

Application Filed
Apr 30, 2018
Under Examination
Nov 27, 2018
Approved for Publication
Oct 2, 2018
Published for Opposition
Oct 2, 2018
Registered

Trademark Image

XAMPENSO

Basic Information

Serial Number
87899784
Filing Date
April 30, 2018
Published for Opposition
October 2, 2018
Abandonment Date
December 30, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 30, 2019
Classes
005

Rights Holder

Fresenius Kabi Deutschland GmbH

16
Address
Else-Kroener-Str. 1
Bad Homburg 61352
DE

Ownership History

Fresenius Kabi Deutschland GmbH

Original Applicant
16
Bad Homburg DE

Fresenius Kabi Deutschland GmbH

Owner at Publication
16
Bad Homburg DE

Legal Representation

Attorney
Scott D. Woldow

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Dec 30, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 30, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
May 15, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 13, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 13, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
May 13, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 27, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 2, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 2, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 12, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 28, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 21, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
May 8, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 3, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for human use, namely, preparations for the treatment of immunological, inflammatory and oncological diseases and disorders and viral infections
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005